Censavudine

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameCensavudine
Drug Alias Name森沙夫定Censavudinum辛沙夫定CensavudinaFestinavir +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsAicardi SyndromeAmyotrophic Lateral SclerosisFrontotemporal Dementia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[17] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesOncolys Biopharma IncTransposon Therapeutics Inc
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsAmyotrophic Lateral SclerosisFrontotemporal DementiaSupranuclear Palsy, Progressive
Inactive IndicationsAicardi SyndromeHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG